{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000193","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.763247+00:00","generated_at":"2026-05-16T03:50:58.375438+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Anavex reports Q1 FY2026 net loss $5.7M; EU blarcamesine setback, re-examination ongoing","bullets":["Net loss of $5.7M ($0.06 per share) vs. $12.1M ($0.14) in Q1 FY2025; R&D expenses dropped to $4.7M from $10.4M.","Cash & equivalents $131.7M (up from $102.6M); company expects cash runway >3 years.","EU CHMP issued negative opinion for blarcamesine in early Alzheimer's; Anavex requested EMA re-examination (Dec 2025).","FDA Type C meeting in Jan 2026 showed interest; company will submit additional Phase IIb/III data for potential NDA.","Appointed Wolfgang Liedtke as SVP Global Head of Neurology; joined ACCESS-AD initiative."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000193","json":"https://secwatch.observer/filing/0001731122-26-000193.json","markdown":"https://secwatch.observer/filing/0001731122-26-000193.md","text":"https://secwatch.observer/filing/0001731122-26-000193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000193/0001731122-26-000193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000193/e7298_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:50:58.375438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}